We observed that, under the standard scenario STD, commencement of therapy at earlier stages of the infection always resulted in higher final total CD4+T cell counts than commencement of therapy at later stages of the infection (Tables 1, 2, 3, 4). The gene discussed is CD4; the disease is infection.